Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1

BMC Cancer

Volumn 3, Issue , 2003, Pages

  Anzick, Sarah L ^a,b   Azorsa, David O ^c   Simons Jr , S Stoney ^d   Meltzer, Paul S ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ESTROGEN RECEPTOR; NUCLEAR PROTEIN; NUCLEAR RECEPTOR COACTIVATOR AMPLIFIED IN BREAST CANCER I; PROTEIN P160; UNCLASSIFIED DRUG; CREBBP PROTEIN, HUMAN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; STEROID RECEPTOR COACTIVATOR 3; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR GENETICS; PHENOTYPIC VARIATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CREB-BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RECEPTORS, ESTROGEN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 3042719057     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-22     Document Type: Article

References (35)

1. McGuire WL, Chamness GC and Fuqua SA: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 1991, 5:1571-1577.
2. Dickson RB and Lippman ME: Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res 1988, 40:119-165.
3. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
4. Dechering K, Boersma C and Mosselman S: Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem 2000, 7:561-576.
5. Robyr D, Wolffe AP and Wahli W: Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 2000, 14:329-347.
6. Kraus WL and Kadonaga JT: p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 1998, 12:331-342.
7. Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
8. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
9. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A and Watson PH: Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res 2000, 60:6266-6271.
10. Bouras T, Southey MC and Venter DJ: Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001, 61:903-907.
11. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N 1989.
12. Azorsa DO and Meltzer PS: Production and characterization of monoclonal antibodies to the steroid receptor coactivator AIB1. Hybridoma 1999, 18:281-287.
13. Azorsa DO, Cunliffe HE and Meltzer PS: Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells. Breast Cancer Res Treat 2001, 70:89-101.
14. Chen Y, Dougherty ER and Bittner ML: Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Optics 1997, 2:364-374.
15. Wang Z, Rose DW, Hermanson O, Liu F, Herman T, Wu W, Szeto D, Gleiberman A, Krones A, Pratt K, Rosenfeld R, Glass CK and Rosenfeld MG: Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A 2000, 97:13549-13554.
16. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ and O'Malley BW: Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998, 279:1922-1925.
17. Doucas V, Tini M, Egan DA and Evans RM: Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A 1999, 96:2627-2632.
18. LaMorte VJ, Dyck JA, Ochs RL and Evans RM: Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A 1998, 95:4991-4996.
19. Baumann CT, Ma H, Wolford R, Reyes JC, Maruvada P, Lim C, Yen PM, Stallcup MR and Hager GL: The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol 2001, 15:485-500.
20. Boisvert FM, Kruhlak MJ, Box AK, Hendzel MJ and Bazett-Jones DP: The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol 2001, 152:1099-1106.
21. Szapary D, Huang Y and Simons SS Jr: Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol 1999, 13:2108-2121.
22. Giannoukos G, Szapary D, Smith CL, Meeker JE and Simons SS Jr: New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties. Mol Endocrinol 2001, 15:255-270.
23. Lopez GN, Webb P, Shinsako JH, Baxter JD, Greene GL and Kushner PJ: Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Mol Endocrinol 1999, 13:897-909.
24. Chen S, Sarlis NJ and Simons SS Jr: Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription. J Biol Chem 2000, 275:30106-30117.
25. Oshima H and Simons SS Jr: Sequence-selective interactions of transcription factor elements with tandem glucocorticoid-responsive elements at physiological steroid concentrations. J Biol Chem 1993, 268:26858-26865.
26. Szapary D, Xu M and Simons SS Jr: Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J Biol Chem 1996, 271:30576-30582.
27. Zeng H, Plisov SY and Simons SS Jr: Ability of the glucocorticoid modulatory element to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of glucocorticoid modulatory element and glucocorticoid response element activities. Mol Cell Endocrinol 2000, 162:221-234.
28. Song LN, Huse B, Rusconi S and Simons SS Jr: Transactivation specificity of glucocorticoid versus progesterone receptors. Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains. J Biol Chem 2001, 276:24806-24816.
29. Kino T, Nordeen SK and Chrousos GP: Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J Steroid Biochem Mol Biol 1999, 70:15-25.
30. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK and Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684.
31. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y and Evans RM: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997, 90:569-580.
32. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK and Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-414.
33. McKenna NJ, Nawaz Z, Tsai SY, Tsai MJ and O'Malley BW: Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc Natl Acad Sci U S A 1998, 95:11697-11702.
34. Yao TP, Ku G, Zhou N, Scully R and Livingston DM: The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci U S A 1996, 93:10626-10631.
35. Zimmet JM, Ladd D, Jackson CW, Stenberg PE and Ravid K: A role for cyclin D3 in the endomitotic cell cycle. Mol Cell Biol 1997, 17:7248-7259.